CXCL8 and colorectal carcinoma: Unexpectedly, a very recent study (in vitro and in vivo) on colorectal cancer (CRC) demonstrated that activation or recruitment of DCs was impeded by blocking CXCL8-CXCR2 axis with CXCR2 antagonists.